Leukemia-cell rejection due to T-region encoded antigens

Area of Science:

• Immunology
• Transplantation Biology
• Genetics

Background:

• The H-2 complex in mice plays a critical role in immune responses, including allogeneic cell rejection.
• Specific regions within H-2, such as K, D, I, and T, encode antigens that influence transplant outcomes.
• Understanding the contribution of each region is vital for advancing transplantation and cancer immunology.

Purpose of the Study:

• To investigate the role of H-2 and T-region gene products in allogeneic leukemia cell rejection.
• To determine whether T-region antigens are involved in tumor transplant rejection.
• To elucidate the specific immune mechanisms underlying transplant rejection in different H-2 congenic and recombinant mouse models.

Main Methods:

• Transplantation of Moloney murine leukemia virus-induced leukemia cell lines (A1ATH and A6ATL) into H-2 congenic and recombinant mice.
• Evaluation of transplant outcomes (rejection or prolonged survival) in hosts with varying incompatibilities in K, D, I, and T regions.
• Assessment of immune responses through pre-immunization with spleen cells and cell-mediated cytotoxicity (CTL) assays.

Main Results:

• Transplant failure occurred in hosts incompatible only in the K- or D-regions.
• Incompatibility in the I + T-regions resulted in either rejection or prolonged survival.
• Leukemia cells were rejected by mice sensitized to T-region products but accepted by those sensitized only to I-region products.
• CTL assays confirmed that T-region products, not I-region products, were specifically targeted by cytotoxic T lymphocytes.

Conclusions:

• Histocompatibility antigens encoded in the T-region of the H-2 complex play a significant role in allogeneic leukemia cell rejection.
• The T-region appears to be a key determinant in tumor-transplant rejection, independent of I-region specific immunity.
• These findings highlight the T-region's importance in immune surveillance against tumors and in transplantation.